Charging Robotics sells 51% of Charging Israel to Clearmind for $2.5M; retains 49%

Charging Robotics Inc.

Clearmind Medicine Inc. to buy 149 ordinary shares of Charging Israel for $2.5M ($16,778/share), giving Clearmind 51% control.
Clearmind also provides $1.5M loan to Charging Israel at 4% p.a., maturing in 3 years, extendable if no positive cash flow.
Company retains 49% stake, accounts for it under equity method; Charging Israel deconsolidated from financials.
Pro forma shows $4.865M gain on deconsolidation for FY2025; pro forma net income attributable to Company $4.818M vs historical loss $387K.
Transaction expected to close week of Sept 7, 2026, subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.